RE: Reminder to all25 Aug 2021 12:04
MrA,
There does not need to be any 'leak' re AVA6k. The simple fact that the trial continues, with doses increasing, is positive. Each day the trial continues, with each increased 3 weekly dose, the risk associated with failure reduces.
Also, re leaks, if AVA6k works as well in humans as it does in mice, it is going to be very obvious that patients are well / have no side effects after each does.